Answers are grounded in this paper and cite their sources.
The objective SCORAD and SCORAD showed a fair responsiveness. The MCIDs are an important prerequisite for the interpretation of published eczema trials and for the planning/sample size estimation of future trials.
No takes yet. Share an insight, caveat, or question.
Schram et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: